データセット
検索結果
-
Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-Elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
Nakamura, I. (作成者), Maegawa, H. (作成者), Tobe, K. (作成者) & Uno, S. (作成者), Adis Journals, 2021
DOI: 10.6084/m9.figshare.14124275, https://adisjournals.figshare.com/articles/media/Safety_and_Effectiveness_of_Ipragliflozin_in_Elderly_Versus_Non-Elderly_Japanese_Patients_with_Type_2_Diabetes_Subgroup_Analysis_of_STELLA-LONG_TERM/14124275
データセット
-
Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-Elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
Nakamura, I. (作成者), Maegawa, H. (作成者), Tobe, K. (作成者) & Uno, S. (作成者), Adis Journals, 2021
DOI: 10.6084/m9.figshare.14124275.v1, https://adisjournals.figshare.com/articles/media/Safety_and_Effectiveness_of_Ipragliflozin_in_Elderly_Versus_Non-Elderly_Japanese_Patients_with_Type_2_Diabetes_Subgroup_Analysis_of_STELLA-LONG_TERM/14124275/1
データセット
-
Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study
Nakamura, I. (作成者), Maegawa, H. (作成者), Tobe, K. (作成者) & Uno, S. (作成者), Adis Journals, 2019
DOI: 10.6084/m9.figshare.7629557, https://adisjournals.figshare.com/articles/Safety_and_Effectiveness_of_Ipragliflozin_for_Type_2_Diabetes_in_Japan_12-Month_Interim_Results_of_the_STELLA-LONG_TERM_Post-Marketing_Surveillance_Study/7629557
データセット